Docusol Plus (Enemeez Inc. DBA Summit Pharmaceuticals)


Welcome to the PulseAid listing for the Docusol Plus drug offered from Enemeez Inc. DBA Summit Pharmaceuticals. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Enemeez Inc. DBA Summit Pharmaceuticals
NON-PROPRIETARY NAME: docusate sodium w/benzocaine
SUBSTANCE NAME: DOCUSATE SODIUM; BENZOCAINE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: RECTAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2013-07-12
END MARKETING DATE: 0000-00-00


Docusol Plus HUMAN OTC DRUG Details:

Item DescriptionDocusol Plus from Enemeez Inc. DBA Summit Pharmaceuticals
LABELER NAME: Enemeez Inc. DBA Summit Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 283; 20(mg/5mL; mg/5mL)
START MARKETING DATE: 2013-07-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17433-9883_05f5eb41-83d7-4549-e054-00144ff8d46c
PRODUCT NDC: 17433-9883
APPLICATION NUMBER: part334

Other DOCUSATE SODIUM; BENZOCAINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Enemeez Inc. DBA Summit PharmaceuticalsDocusol Plus
Summit PharmaceuticalsCVS Adult Enema